139 related articles for article (PubMed ID: 29312570)
1. Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma.
Liu HN; Wu H; Chen YJ; Tseng YJ; Bilegsaikhan E; Dong L; Shen XZ; Liu TT
Oncotarget; 2017 Dec; 8(65):108810-108824. PubMed ID: 29312570
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer.
Liu HN; Wu H; Tseng YJ; Chen YJ; Zhang DY; Zhu L; Dong L; Shen XZ; Liu TT
BMC Cancer; 2018 Apr; 18(1):415. PubMed ID: 29653559
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods.
Liu HN; Liu TT; Wu H; Chen YJ; Tseng YJ; Yao C; Weng SQ; Dong L; Shen XZ
Cancer Sci; 2018 Apr; 109(4):1185-1194. PubMed ID: 29363233
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
5. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
Jiang L; Cheng Q; Zhang BH; Zhang MZ
Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
[TBL] [Abstract][Full Text] [Related]
8. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.
Moshiri F; Salvi A; Gramantieri L; Sangiovanni A; Guerriero P; De Petro G; Bassi C; Lupini L; Sattari A; Cheung D; Veneziano D; Nigita G; Shankaraiah RC; Portolani N; Carcoforo P; Fornari F; Bolondi L; Frassoldati A; Sabbioni S; Colombo M; Croce CM; Negrini M
Oncotarget; 2018 Mar; 9(20):15350-15364. PubMed ID: 29632649
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
Sun Q; Li J; Jin B; Wang T; Gu J
Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
14. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
15. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
Lin L; Lu B; Yu J; Liu W; Zhou A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
18. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
[TBL] [Abstract][Full Text] [Related]
19. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
Cho HJ; Baek GO; Seo CW; Ahn HR; Sung S; Son JA; Kim SS; Cho SW; Jang JW; Nam SW; Cheong JY; Eun JW
Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
[TBL] [Abstract][Full Text] [Related]
20. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.
Shi BM; Lu W; Ji K; Wang YF; Xiao S; Wang XY
World J Gastroenterol; 2017 May; 23(20):3713-3720. PubMed ID: 28611524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
